hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

AstraZeneca

Member of UN Global Compact

Headquarters in United Kingdom

AstraZeneca website

Response rate: 100%

(click here for an explanation)

🔎 Run a search for “AstraZeneca”

Get RSS feed of these results

All stories

Company response
6 September 2006

Response by AstraZeneca: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including AstraZeneca - finds none has comprehensive approach.

Read full response

Article
17 August 2006

[PPT] presentation: "Benchmarking AIDS: Evaluating pharmaceutical company responses to the public health crisis in emerging markets"

Author: Daniel Rosan, Program Director for Public Health, Interfaith Center on Corporate Responsibility [USA]

[identifies pharmaceutical best practice in key areas including research, paediatric needs, drug accessibility, reporting, philanthropy, political engagement; rates 15 top pharmaceutical firms on each practice: Abbott Laboratories, AstraZeneca,...

Read more

Story
14 August 2006

Interfaith Center on Corporate Responsibility - new report on pharmaceutical firms' responses to AIDS

See full story

Article
14 August 2006

New Report: Top pharma companies fail to address industry best practices on HIV/AIDS

Author: Interfaith Center on Corporate Responsibility [USA]

The Interfaith Center on Corporate Responsibility released a comprehensive scorecard evaluating the pharmaceutical industry's efforts in the fight against HIV/AIDS...The ICCR report highlights the large disparities between industry best practices in...

Read more

Article
17 July 2006

Global health feature: Taking the Global Pulse - Threats and Solutions

Author: Zarrin T. Caldwell, OneWorld US

With an eye toward their bottom lines, big pharmaceutical companies typically invest in research and development for new drugs and vaccines that promise a profit...[the] companies generally assert that they have played an important role in developing...

Read more

Article
19 June 2006

The 25 Noteworthy Companies [USA]

Author: DiversityInc

The 25 Noteworthy Companies were close to making The 2006 DiversityInc Top 50 Companies list and all excel in at least one, and in most cases several, of the four areas we measure—CEO commitment, human capital, corporate communications and supplier...

Read more

Story
1 June 2006

Consumers Intl. says 20 top drug companies' marketing practices mislead the public on drug safety

See full story

Article
1 June 2006

[PDF] Branding the Cure: A consumer perspective on Corporate Social Responsibility, Drug Promotion and the Pharmaceutical Industry

Author: Consumers International

Main findings: Limited transparency in reporting CSR information...New marketing tactics may not be to consumers’ benefit...Breaches of regulations and CSR codes occur with regular frequency showing weak industry self-regulation...Strong and effective...

Read more

Article
1 June 2006
+ Español - Hide

Author: Consumers International

Resultados principales: Transparencia limitada a la hora de informar sobre RSE...Las nuevas tácticas de publicidad pueden no beneficiar a los consumidores...Las violaciones de los reglamentos y códigos de RSE ocurren con frecuencia periódica, lo cual...

Read more

Article
1 June 2006
+ Français - Hide

Author: Consumers International

Les principaux résultats: Transparence limitée en matière de signalement des informations relatives à la RSE...Il se peut que les nouvelles tactiques marketing ne soient pas dans l’intérêt des consommateurs...Des violations des règlements et codes RSE...

Read more